drugset / Trial / NCT00206180
NEXIUM® in the Treatment of Moderate and Severe Erosive Esophagitis
RandomizedParallel-groupDouble-blind
Summary
The purpose of this study is to decide if controlling stomach acid is related to healing of erosive esophagitis after treatment with esomeprazole magnesium (NEXIUM®) 10 mg and 40 mg once daily.
Timeline
- Start
- 2004-06
- Primary completion
- —
- Completion
- 2005-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esomeprazole | Small molecule | 10 mg | Oral |
| Subject | Esomeprazole | Small molecule | 40 mg | Oral |